{"id":"https://openalex.org/W2048359273","doi":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","title":"Why blockade of the renin\u2013angiotensin system reduces the incidence of new-onset diabetes","display_name":"Why blockade of the renin\u2013angiotensin system reduces the incidence of new-onset diabetes","publication_year":2005,"publication_date":"2005-02-15","ids":{"openalex":"https://openalex.org/W2048359273","doi":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","mag":"2048359273","pmid":"https://pubmed.ncbi.nlm.nih.gov/15716683"},"language":"en","primary_location":{"id":"doi:10.1097/01.hjh.0000160198.05416.72","doi":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030776630","display_name":"Karin Agnes Maria Jandeleit-Dahm","orcid":"https://orcid.org/0000-0003-2192-5822","observed_orcids":["https://orcid.org/0000-0003-2192-5822"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Karin AM Jandeleit-Dahm","raw_affiliation_strings":["Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia. karin.jandeleit-dahm@baker.edu.au","Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","e-mail: [email\u00a0protected]","fax: +61 38532 1288","requests for reprints to Karin Jandeleit-Dahm, MD, PhD, Vascular Division, Wynn Domain, The Baker Heart Research Institute, Commercial Road, Melbourne 3004, Victoria, Australia. Tel: +61 39276 2983"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia. karin.jandeleit-dahm@baker.edu.au","institution_ids":["https://openalex.org/I142471025"]},{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I142471025"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +61 38532 1288","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Karin Jandeleit-Dahm, MD, PhD, Vascular Division, Wynn Domain, The Baker Heart Research Institute, Commercial Road, Melbourne 3004, Victoria, Australia. Tel: +61 39276 2983","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110687422","display_name":"Christos Tikellis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christos Tikellis","raw_affiliation_strings":["Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058800016","display_name":"Christopher Michael Reid","orcid":"https://orcid.org/0000-0001-9173-3944","observed_orcids":["https://orcid.org/0000-0001-9173-3944","https://orcid.org/0000-0002-9101-1447","https://orcid.org/0000-0002-6429-1180"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christopher M Reid","raw_affiliation_strings":["Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103431288","display_name":"Colin I. Johnston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Colin I Johnston","raw_affiliation_strings":["Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I142471025"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062670268","display_name":"Mark Emmanuel Cooper","orcid":"https://orcid.org/0000-0001-7785-2488","observed_orcids":["https://orcid.org/0000-0001-7785-2488"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mark E Cooper","raw_affiliation_strings":["Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danielle Alberti Centre for Diabetes Complications, Vascular Division, Wynn Domain, Baker Heart Research Institute, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I142471025"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030776630"],"corresponding_institution_ids":["https://openalex.org/I142471025"],"apc_list":null,"apc_paid":null,"fwci":6.1989,"has_fulltext":false,"cited_by_count":293,"citation_normalized_percentile":{"value":0.98510029,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"23","issue":"3","first_page":"463","last_page":"473"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7870000004768372},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes-prevention","display_name":"type 2 diabetes prevention","score":0.8799999952316284},{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.871999979019165},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.984000027179718},{"id":"https://openalex.org/keywords/beta-cell-death","display_name":"beta-cell death","score":0.7960000038146973},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.7080000042915344},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.46700000762939453},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.4020000100135803},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.6830000281333923},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7639999985694885},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.9210000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9695615768432617},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.7880254983901978},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.7359052896499634},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5944781303405762},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.500978946685791},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43790706992149353},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.28056538105010986},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08539921045303345},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.07379546761512756},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.hjh.0000160198.05416.72","doi":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000160198.05416.72","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:15716683","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15716683","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W200260629","https://openalex.org/W1592471891","https://openalex.org/W1604542334","https://openalex.org/W1965894638","https://openalex.org/W1969961684","https://openalex.org/W1971845216","https://openalex.org/W1972866300","https://openalex.org/W1974548284","https://openalex.org/W1976882677","https://openalex.org/W1980567021","https://openalex.org/W1981496033","https://openalex.org/W1983526026","https://openalex.org/W1984347576","https://openalex.org/W1984513597","https://openalex.org/W1989262229","https://openalex.org/W1990941703","https://openalex.org/W1992231742","https://openalex.org/W2001212657","https://openalex.org/W2003761033","https://openalex.org/W2011209243","https://openalex.org/W2013185641","https://openalex.org/W2014972723","https://openalex.org/W2023531846","https://openalex.org/W2026078677","https://openalex.org/W2027132254","https://openalex.org/W2028406751","https://openalex.org/W2032164458","https://openalex.org/W2034019200","https://openalex.org/W2036266922","https://openalex.org/W2044397645","https://openalex.org/W2044790637","https://openalex.org/W2057556314","https://openalex.org/W2059165993","https://openalex.org/W2063396563","https://openalex.org/W2068994621","https://openalex.org/W2069883941","https://openalex.org/W2070252369","https://openalex.org/W2075980045","https://openalex.org/W2082854134","https://openalex.org/W2086987865","https://openalex.org/W2093034072","https://openalex.org/W2097784879","https://openalex.org/W2098780362","https://openalex.org/W2099142346","https://openalex.org/W2102979143","https://openalex.org/W2107165439","https://openalex.org/W2109861453","https://openalex.org/W2110182057","https://openalex.org/W2116125200","https://openalex.org/W2117939109","https://openalex.org/W2118194784","https://openalex.org/W2122966913","https://openalex.org/W2125694416","https://openalex.org/W2130718279","https://openalex.org/W2133217116","https://openalex.org/W2134293572","https://openalex.org/W2135038122","https://openalex.org/W2135458024","https://openalex.org/W2139016545","https://openalex.org/W2139551405","https://openalex.org/W2139805666","https://openalex.org/W2142834180","https://openalex.org/W2146851676","https://openalex.org/W2147071181","https://openalex.org/W2150035134","https://openalex.org/W2153913481","https://openalex.org/W2154851491","https://openalex.org/W2155252568","https://openalex.org/W2155699563","https://openalex.org/W2156121263","https://openalex.org/W2156783035","https://openalex.org/W2158132515","https://openalex.org/W2159632385","https://openalex.org/W2166836178","https://openalex.org/W2171655301","https://openalex.org/W2305118939","https://openalex.org/W2330973319","https://openalex.org/W2334899541","https://openalex.org/W2413492725","https://openalex.org/W2418772056","https://openalex.org/W2462311345","https://openalex.org/W2562329777","https://openalex.org/W4242344507","https://openalex.org/W4254784503","https://openalex.org/W6811861438"],"related_works":["https://openalex.org/W1983793555","https://openalex.org/W1975073519","https://openalex.org/W1990950873","https://openalex.org/W2151871061","https://openalex.org/W2090561884","https://openalex.org/W2313314614","https://openalex.org/W63288844","https://openalex.org/W2069711524","https://openalex.org/W1561463821","https://openalex.org/W3028772122"],"abstract_inverted_index":{"Recent":[0],"trials":[1,54],"have":[2],"suggested":[3],"that":[4,133,196,222],"inhibitors":[5,16,63,88,158,198,260],"of":[6,27,40,61,69,76,83,101,124,152,168,207,220,246,249,261,285,292],"the":[7,25,49,106,134,165,180,205,224,243,247,259,262,281,290],"renin-angiotensin":[8],"system":[9],"(RAS),":[10],"such":[11,56,97,271],"as":[12,98,272],"angiotensin-converting":[13],"enzyme":[14],"(ACE)":[15],"and":[17,36,64,103,110,119,159,176,199,210,230,277],"angiotensin":[18,169],"II":[19,170],"receptor":[20],"blockers":[21,275],"(ARBs),":[22],"may":[23,136,161,201],"reduce":[24],"incidence":[26,75],"new-onset":[28],"diabetes":[29,77,85,231,250],"in":[30,78,139,148,179,235],"patients":[31,79],"with":[32,242],"or":[33,89,203],"without":[34],"hypertension":[35],"at":[37,80],"high":[38,81],"risk":[39,82],"developing":[41,84],"diabetes.":[42,155,293],"In":[43],"this":[44],"review,":[45],"we":[46],"critically":[47],"evaluate":[48,280],"evidence":[50,132,193],"from":[51],"recent":[52,71],"clinical":[53,240],"for":[55,189,212],"a":[57,67,184],"potential":[58,282],"preventive":[59],"effect":[60,167],"ACE":[62,87,157,197],"ARBs,":[65],"including":[66,113],"meta-analysis":[68],"these":[70],"trials.":[72],"The":[73,218],"reduced":[74],"by":[86,94,163],"ARBs":[90,160,200],"has":[91],"been":[92],"explained":[93],"haemodynamic":[95],"effects,":[96,112],"improved":[99],"delivery":[100],"insulin":[102,120,127,190,208,227],"glucose":[104,117],"to":[105,145,254,267,279],"peripheral":[107],"skeletal":[108],"muscle,":[109],"non-haemodynamic":[111],"direct":[114],"effects":[115,284],"on":[116,171,226,289],"transport":[118],"signalling":[121],"pathways,":[122],"all":[123],"which":[125,143,213],"decrease":[126],"resistance.":[128],"There":[129],"is":[130,194],"now":[131,252],"pancreas":[135],"contain":[137],"an":[138,149],"situ":[140],"active":[141],"RAS,":[142],"appears":[144],"be":[146],"upregulated":[147],"animal":[150,237],"model":[151],"type":[153],"2":[154],"Thus,":[156],"act":[162],"attenuating":[164],"deleterious":[166],"vasoconstriction,":[172],"fibrosis,":[173],"inflammation,":[174],"apoptosis":[175],"beta-cell":[177,186],"death":[178],"pancreas,":[181],"thereby":[182],"protecting":[183],"critical":[185],"mass":[187],"essential":[188],"production.":[191],"New":[192],"presented":[195],"delay":[202],"prevent":[204],"development":[206,291],"resistance":[209],"diabetes,":[211],"novel":[214],"mechanisms":[215],"are":[216,251,264],"suggested.":[217],"actions":[219],"agents":[221,270],"interrupt":[223],"RAS":[225,263],"resistance,":[228],"obesity":[229],"warrant":[232],"further":[233,256],"investigation":[234],"other":[236,268],"models.":[238],"Prospective":[239],"studies":[241],"primary":[244],"endpoint":[245],"prevention":[248],"indicated":[253],"(i)":[255],"explore":[257],"whether":[258],"superior":[265],"compared":[266],"antihypertensive":[269,287],"calcium":[273],"channel":[274],"(CCBs)":[276],"(ii)":[278],"beneficial":[283],"combination":[286],"regimens":[288]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}